|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.975 USD | +0.63% |
|
-5.54% | -38.00% |
| 05-14 | Aquestive Therapeutics, Inc., Q1 2026 Earnings Call, May 14, 2026 | |
| 05-14 | Aquestive Therapeutics Inc - enters five-year term loan facility of up to $150 million on May 12, 2026 - SEC filing | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Neutral |
| Resistance | 5.03 | 5.03 | 7.08 |
| Spread/Res. | -20.38% | -20.38% | -43.43% |
| Spread/Supp. | +2.43% | +2.43% | +35.76% |
| Support | 3.91 | 3.91 | 2.95 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AQST Stock
- Charts Aquestive Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
